MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_Stem Cell Therapeutics
Cell Targeting
Parents
*Portfolio Companies: Toucan
Architects: Biotechnology_Stem Cell Therapeutics
Companies: Acquired_(M&A)
Finance & Acquisition: BioTime
Industry: Ohio
Children
2011: BioTime Acquires Assets of Cell Targeting, Inc. (2011)
Cleveland, Ohio
Developing Technology that Can Point Stem Cell Therapies to Specific Areas of the Body.
Regenerative medicine startup Cell Targeting sold to BioTime (2011)
Toucan Capital invested $1 million in Cell Targeting and the company also has a piece of a $10 million state grant to develop its product.
Jumps
Case Western Reserve University